• 1
    Fracheboud J, Koning de HJ, Beemsterboer PMM, Boer R, Hendriks JHCL, Verbeek ALM, van Ineveld BM, de Bruyn AE, van der Maas PJ. Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990–1995. Int J Cancer 1998;75: 6948.
  • 2
    Jackman RJ, Marzoni FA. Needle-localized breast biopsy: why do we fail? Radiology 1997;204: 67784.
  • 3
    Parker SH, Lovin JD, Jobe WE, Luethke JM, Hopper KD, Yakes WF, Burke BJ. Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176: 7417.
  • 4
    Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SD, Shephard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimate rates after long-term follow up. Radiology 1999;210: 799805.
  • 5
    Meyer JE, Eberlein TJ, Stomper PC, Sonnenfeld MR. Biopsy of occult breast lesions: analysis of 1261 abnormalities. J Am Med Assoc 1999;263: 23413.
  • 6
    Verkooijen HM, Peeters PHM, Buskens E, Koot VCM, Borel Rinkes IHM, Mali WPThM, van Vroonhoven ThJMV. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer 2000;85: 101721.
  • 7
    Gisvold JJ, Goellner JR, Grant CS, Donohue JH, Sykes MW, Karsell PR, Coffey SL, Jung SH. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR 1994;162: 81520.
  • 8
    Pijnappel RM, Dalen van A, Borel Rinkes IHM, Tweel van den JG, Mali WPThM. The diagnostic accuracy of core biopsy in palpable and non-palpable breast lesions. Eur J Radiol 1997;24: 1203.
  • 9
    Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gauge breast biopsy: how many core specimens are needed? Radiology 1994;192: 7935.
  • 10
    Liberman L, Evans WP, Dershaw DD, Hahn LE, Deutch BM, Abramson AF, Rosen PP. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 1994;190: 2235.
  • 11
    Burbank F, Parker SH. Methods for evaluating the quality of an image-guided breast biopsy program. Sem Breast Dis 1998;1: 7183.
  • 12
    Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR 1995;164: 11113.
  • 13
    Brown TA, Wall JW, Christensen ED, Smith DV, Holt CA, Carter PL, Patience TH, Babu SS, Williard WC. Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol 1998;67: 16873.
  • 14
    Gadzala DE, Cederbom GJ, Bolton JS, McKinnon WM, Farr GH, Champaign J, Ordoyne K, Chung K, Fuhrman GM. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 1997;4: 2836.
  • 15
    Tavassoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998;11: 14054.
  • 16
    Page DL, Jensen RA, Simpson JF. Premalignant and malignant disease of the breast: the roles of the pathologist. Mod Pathol 1998;11: 1208.
  • 17
    Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne CB, London SJ, Colditz GA. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6: 297301.
  • 18
    Verkooijen HM, Peeters PHM, Pijnappel RM, Koot VCM, Schipper MEI, Borel Rinkes IHM. Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg 2000;87: 3447.
  • 19
    Brenner RJ, Basset LW, Fajardo LL, Dershaw DD; Evans WP, Hunt R, Tocino I, Fisher P, McCombs M, Jackson VP, Feig SA, Mendelson EB, et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology 2001;218: 86672.
  • 20
    Morrow M, Venta L, Stinson T, Bennet C. Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 2001;233: 53741.
  • 21
    Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, Coscia JL, Eklund GW, Evans WP, Garver PR. Percutaneous large-core breast biopsy: A multi-institutional study. Radiology 1994;193: 35964.
  • 22
    Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, Evans WP, Tocino I, McNeil BJ. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. Cancer 1998;82: 67988.
  • 23
    Philpotts LE, Lee CH, Horvath LJ, Tocino I. Canceled stereotactic core-needle biopsy of the breast: analysis of 89 cases. Radiology 1997;205: 4238.
  • 24
    Verkooijen HM, Peeters PHM, Borel Rinkes IHM, Pijnappel RM, Kaya A, Mali WPThM, van Vroonhoven ThJMV. Risk factors for cancellation of stereotactic large-core needle biopsy on a prone biopsy table. Br J Radiol 2001;74: 100712.
  • 25
    Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340: 4306.
  • 26
    Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000;216: 8317.
  • 27
    Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998;208: 71723.
  • 28
    Burak WE, Owens KE, Tighe MB, Kemps L, Dinges SA, Hitchcock CL, Olsen J. 2000. Vacuum-assisted stereotactic breast biopsy: Histologic underestimation of malignant lesions. Arch Surg 2000;135: 7003.